EW News and Press, Edwards Lifesciences Corporation From 07/15/20

IRVINE, Calif. , July 15, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Paul A. LaViolette has been appointed to its board of directo...

Abbott Laboratories (NYSE: ABT) and Edwards Lifesciences (NYSE: EW) are burying the hatchet. The two healthcare companies announced in separate press releases that they have reached a settlement on a set of patent disputes centered on heart valve devices. It puts to rest a dispute tha...

Abbott (NYSE: ABT ) announces that it has settled all outstanding patent disputes with Edwards Lifesciences (NYSE: EW ) related to transcatheter mitral and tricuspid repair products. More news on: Abbott Laboratories, Edwards Lifesciences Corporation, Healthcare stocks news, Stocks on th...

IRVINE, Calif. , July 13, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has reached an agreement with Abbott to settle all outstanding pa...

IRVINE, Calif. , July 9, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2020 after the ma...

Introduction This article is a follow-up to a series of articles I recently wrote about how to avoid losses and how to profit from sentiment cycles. If you are already familiar with the strategy, feel free to skip down to the "Highlighted Stock of the Month" section and read from there. If y...

While economic uncertainty continues to be high, I want to invest in companies that are looking to solve today’s biggest problems. This leads me to a fast-growing player in healthcare: Abiomed Inc (NASDAQ: ABMD). Even at 14x revenue and 56x forward earnings, Abiomed is priced at a reaso...

Edwards Lifesciences (NYSE: EW) is a little-known medical device company that produces medical hardware including aortic valve replacements, blood sampling systems, and surgical recovery equipment. Though established medical device companies like Edwards may not be the first place that would...

This article is part of a series that provides an ongoing analysis of the changes made to Wedgewood Partners’ 13F stock portfolio on a quarterly basis. It is based on David Rolfe’s regulatory 13F Form filed on 04/29/2020. The 13F portfolio value decreased ~47% from $987M to $52...

A Deeper Look Reveals New Concerns and Adds To Our Conviction Zynex (NASDAQ: ZYXI ) shares are up 150% year to date vs the Health Care Select SPDR ETF (NYSE: XLV) at -2%. We believe ZYXI's outperformance is a function of retail investor complacency combined with sell-side analyst careless...